nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo searchdiv qikanlogo popupnotification paper paperNew
2019 03 v.40;No.168 237-240
盐酸羟考酮缓释片对老年晚期非小细胞肺癌患者镇痛效果及炎症因子水平的影响

Summary

Note: Please note that the following content is generated by AI. CNKI does not take any responsibility related to this content.
基金项目(Foundation):
邮箱(Email): LIW129388@163.com;
DOI:
3 78 12
阅读 下载 被引

工具集

引用本文 下载本文
PDF
引用导出 分享

    扫码分享到微信或朋友圈

使用微信“扫一扫”功能。
将此内容分享给您的微信好友或者朋友圈
摘要:

目的探讨盐酸羟考酮缓释片对老年晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)患者的镇痛效果及对患者血清炎症因子水平的影响。方法选取2015年3月至2017年3月公安县人民医院收治的年龄大于60岁的老年晚期NSCLC患者100例,按照随机数字表法分为观察组与对照组,每组50例。对照组在常规化疗治疗的同时给予硫酸吗啡缓释片镇痛,观察组在常规化疗治疗的同时给予盐酸羟考酮缓释片镇痛。观察比较2组患者镇痛有效率、起效时间及不良反应发生情况;检测治疗前后2组患者血清中白细胞介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)水平。结果对照组患者治疗后镇痛总有效率为82.0%,镇痛起效时间为(2.51±0.23)h,不良反应发生率为36.0%;观察组患者治疗后镇痛总有效率为92.0%,镇痛起效时间为(0.87±0.11)h,不良反应发生率为24.0%。两者比较差异有统计学意义(P<0.05)。治疗后,对照组和观察组患者血清中IL-6及TNF-α水平均明显低于本组治疗前;观察组患者治疗后血清中IL-6及TNF-α水平均明显低于对照组治疗后,差异均有统计学意义(P<0.05)。结论盐酸羟考酮缓释片对老年晚期NSCLC患者具有较好的镇痛效果,具有起效时间短,不良反应发生率低,安全性高等优点,同时还可显著缓解患者炎性反应状态。

Abstract:

Objective To investigate the effects of oxycodone hydrochloride slow-release tablets on analgesia and inflammatory factors in old patients with advanced non-small cell lung cancer(NSCLC).Methods One hundred patients with advanced NSCLC with an age over 60 years who were admitted in People′s hospital, Gongan county for treatment from March 2015 to March 2017 were selected as research subjects and were randomly divided into the observation group and the control group, each consisting of 50 patients. The control group received morphine sulfate slow-release tablets for analgesia supplemented with conventional chemotherapy at the same time, and the observation group was given oxycodone hydrochloride slow-release tablets for analgesia supplemented with conventional chemotherapy. The analgesic efficiency, onset time and adverse reactions were observed and compared between the 2 groups. The levels of IL-6 and TNF-α in the serum of the patients in the two groups were detected before and after treatment.Results The total effective rate of analgesia in the control group after treatment was 82%, the onset time of analgesia was(2.51±0.23) h and the rate of adverse reactions was 36.0%, while the total effective rate of analgesia in the observation group after treatment was 92.0%, the onset time of analgesia was(0.87±0.11) h and the rate of adverse reactions was 24.0%. Statistical significance could be noticed, when comparisons were made between the 2 groups(P<0.05). Following treatment, the serum levels of IL-6 and TNF-α in the patients of both the control group and the observation group were significantly lower than those before treatment, and the levels of serum IL-6 and TNF-α of the patients in the observation group were significantly lower than those in the control group after treatment, also with statistical significance(P<0.05).Conclusion Oxycodone hydrochloride slow-release tablets could exert good analgesic effects on old patients with advanced NSCLC, and have the advantages of short onset time, low rate of adverse reactions and good safety, and at the same time it could significantly alleviate inflammatory reaction of patients.

参考文献

[1] Hu B,Zhou X,Liu Y,et al.Comparison of chemotherapy plus bevacizumab vs.chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer:a propensity score-matched analysis[J].Oncol Lett,2018,15(4):5671-5679.DOI:10.3892/ol.2018.8064.

[2] Alifrangis C,Carter P,Cereser B,et al.Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments[J].Oncotarget,2018,9(16):12805-12811.DOI:10.18632/oncotarget.24375.

[3] 张润萍,武晓波,戚洁.T细胞亚群与NK细胞在初诊非小细胞肺癌患者外周血中的水平以及与预后的相关性分析[J].海军医学杂志,2017,38(2):175-177.DOI:10.3969/j.issn.1009-0754.2017.02.026.

[4] Swarm RA,Dans M.NCCN Frameworks for resource stratification of NCCN guidelines:adult cancer pain and palliative care[J].J Natl Compr Canc Netw,2018,16(5S):628-631.DOI:10.6004/jnccn.2018.0044.

[5] Janknegt R,van den Beuken M,Schiere S,et al.Rapid acting fentanyl formulations in breakthrough pain in cancer:drug selection by means of the system of objectified judgement analysis[J].Eur J Hosp Pharm Sci Pract,2018,25(3):e2.DOI:10.6004/jnccn.2018.0044.

[6] 常国祥,凌金祖,郭伟,等.不同剂量高乌甲素联合硫酸吗啡缓释片治疗老年中重度癌痛的临床观察[J].实用老年医学,2017,31(2):146-149.DOI:10.3969/j.issn.1003-9198.2017.02.013.

[7] 李静,庄雪梅,杨宗凡,等.奥施康定联合罗通定治疗老年晚期癌痛患者中重度疼痛的临床研究[J].现代肿瘤医学,2014,22(9):2191-2194.DOI:10.3969/j.issn.1672-4992.2014.09.60.

[8] 杨平.国际肺癌研究会非小细胞肺癌新分期系统解析[J].转化医学杂志,2010,23(2):97-99.DOI:10.3969/j.issn.1009-3427.2010.02.011.

[9] 黄孟芹,李成发,孔凡良,等.盐酸羟考酮缓释片治疗中晚期恶性肿瘤疼痛的临床有效性观察[J].安徽医药,2015,19(10):2022-2023.DOI:10.3969/j.issn.1009-6469.2015.10.060.

[10] 张军,王超,崔红梅,等.高压氧联合小细胞肺癌化疗方案治疗晚期非小细胞肺癌对患者生活质量的影响[J].中华航海医学与高气压医学杂志,2016,23(5):401-403.DOI:10.3760/cma.j.issn.1009-6906.2016.05.019.

[11] 李良,吴瑞锋,刘子滕,等.GP化疗联合同步放疗治疗老年非小细胞肺癌的疗效及对免疫功能、生活质量的影响[J].实用老年医学,2017,31(5):461-464.DOI:10.3969/j.issn.1003-9198.2017.05.017.

[12] 丁忠海,计婧,许林,等.表皮生长因子受体酪氨酸激酶抑制剂一线治疗老年晚期非小细胞肺癌的临床研究[J].实用老年医学,2017,31(4):419-423.DOI:10.3969/j.issn.1003-9198.2017.04.006.

[13] Lucenteforte E,Vagnoli L,Pugi A,et al.A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study[J].BMC,2018,18(1):568.DOI:10.1186/s12885-018-4478-3.

基本信息:

DOI:

中图分类号:R734.2

引用信息:

[1]张红霞,李炜,许学萍.盐酸羟考酮缓释片对老年晚期非小细胞肺癌患者镇痛效果及炎症因子水平的影响[J].海军医学杂志,2019,40(03):237-240.

基金信息:

文档文件

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文